Oleksii Nikolaienko
Stilling
forsker, Brystkreftgruppen ved Mohn kreftforskningslaboratorium
Tilhørighet
Forskergrupper
Publikasjoner
2017
- Agata Gozdz; Oleksii Nikolaienko; Malgorzata Urbanska et al. (2017). GSK3α and GSK3β Phosphorylate Arc and Regulate its Degradation. (ekstern lenke)
- Craig Myrum; Oleksii Nikolaienko; Clive R. Bramham et al. (2017). Implication of the APP gene in intellectual abilities. (ekstern lenke)
- Oleksii Nikolaienko; Sudarshan Patil; Maria Steene Eriksen et al. (2017). Arc protein: a flexible hub for synaptic plasticity and cognition. (ekstern lenke)
- Oleksii Nikolaienko; Maria Steene Eriksen; Sudarshan Patil et al. (2017). Stimulus-evoked ERK-dependent phosphorylation of activity-regulated cytoskeleton-associated protein (Arc) regulates its neuronal subcellular localization. (ekstern lenke)
2022
- Oleksii Nikolaienko; Per Eystein Lønning; Stian Knappskog (2022). ramr: an R/Bioconductor package for detection of rare aberrantly methylated regions. (ekstern lenke)
- Per Eystein Lønning; Oleksii Nikolaienko; Kathy Pan et al. (2022). Constitutional BRCA1 methylation and risk of incident triple-negative breast cancer and high-grade serous ovarian cancer. (ekstern lenke)
2025
- Per Eystein Lønning; Oleksii Nikolaienko; Stian Knappskog (2025). Triple-Negative Breast Cancer on the Rise or…? [Letter]. (ekstern lenke)
- Per Eystein Lønning; Oleksii Nikolaienko; Stian Knappskog (2025). Constitutional Epimutations: From Rare Events Toward Major Cancer Risk Factors?. (ekstern lenke)
- Per Eystein Lønning; Oleksii Nikolaienko; Stian Knappskog (2025). Comments on the paper “Extensive epigenomic dysregulation is a hallmark of homologous recombination deficiency in triple-negative breast cancer” by Y. Chen et al.. (ekstern lenke)
- Oleksii Nikolaienko; Garnet L. Anderson; Rowan T. Chlebowski et al. (2025). MGMT epimutations and risk of incident cancer of the colon, glioblastoma multiforme, and diffuse large B cell lymphomas. (ekstern lenke)
2023
- Oleksii Nikolaienko; Hans Petter Eikesdal; Elisabet Ognedal Berge et al. (2023). Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development. (ekstern lenke)
- Oleksii Nikolaienko; Per Eystein Lønning; Stian Knappskog (2023). epialleleR: an R/Bioconductor package for sensitive allele-specific methylation analysis in NGS data. (ekstern lenke)
- Synnøve Yndestad; Christina Engebrethsen; A. Herencia-Ropero et al. (2023). Homologous Recombination Deficiency Across Subtypes of Primary Breast Cancer. (ekstern lenke)
2024
- Per Eystein Lønning; Oleksii Nikolaienko; Stian Knappskog (2024). Constitutional BRCA1 Epimutations: A Key for Understanding Basal-Like Breast and High-Grade Serous Ovarian Cancer. (ekstern lenke)
- Per Eystein Lønning; Oleksii Nikolaienko; Stian Knappskog (2024). Letter to the Editor in response to paper “BRCA1 promoter methylation in triple-negative breast cancer……” by K Daster et al. (ekstern lenke)
Se en full oversikt over publikasjoner i Cristin
Up-to-date publication lists at Google Scholar, PubMed, ORCID. Preprints at bioRxiv, medRxiv.
Prosjekter
Principal Investigator:
- 2026/01-2028/12 — Molecular predisposition to multiple primary melanoma (Western Norway Regional Health Authority, ~420 kEUR)
- 2025/07-2028/06 — Mosaic epimutations: population prevalence, mechanistic origins, and their role in cancer (Research Council of Norway, ~1 MEUR)
- 2025/01-2027/12 — Mosaic epimutations: population prevalence, mechanistic origins, and their role in cancer (Norwegian Cancer Society, ~680 kEUR)
- 2024/01-2025/12 — Low-level epimutational mosaicism in tumour suppressor genes—a generic cancer risk factor (Norwegian Cancer Society, ~170 kEUR)
- 2015/01-2017/12 — Translational neuropsychiatry: impact of genetic variations in synaptic plasticity-related genes (Bergens Forskningsstiftelse / Trond Mohn Research Foundation, ~370 kEUR)
Project Participant:
- 2022/01-2024/12 — Epimutations in MGMT and MLH1 and risk of cancers of the colon, endometrium and glioblastomas (Western Norway Regional Health Authority, ~450 kEUR)